These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27902723)
1. Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study. Li H; Li L; Gu J; Li Y; Chen X; Yang D PLoS One; 2016; 11(11):e0167036. PubMed ID: 27902723 [TBL] [Abstract][Full Text] [Related]
2. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome. Wen X; Wang L; Bai E Front Endocrinol (Lausanne); 2024; 15():1370578. PubMed ID: 39109080 [TBL] [Abstract][Full Text] [Related]
3. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207 [TBL] [Abstract][Full Text] [Related]
4. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199 [TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419 [TBL] [Abstract][Full Text] [Related]
6. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Yilmaz M; Isaoglu U; Delibas IB; Kadanali S J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088 [TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Chae SJ; Kim JJ; Choi YM; Hwang KR; Jee BC; Ku SY; Suh CS; Kim SH; Kim JG; Moon SY Hum Reprod; 2008 Aug; 23(8):1924-31. PubMed ID: 18579512 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population. Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype. Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria. Guo M; Chen ZJ; Macklon NS; Shi YH; Westerveld HE; Eijkemans MJ; Fauser BC; Goverde AJ Reprod Biomed Online; 2010 Oct; 21(4):572-80. PubMed ID: 20800551 [TBL] [Abstract][Full Text] [Related]
11. [Clinical, hormonal and metabolic characteristics of different phenotypes of polycystic ovary syndrome, in Bulgarian population]. Kavardzhikova S; Pechlivanov B Akush Ginekol (Sofiia); 2010; 49(4):32-7. PubMed ID: 20734639 [TBL] [Abstract][Full Text] [Related]
12. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes. Romualdi D; Di Florio C; Tagliaferri V; De Cicco S; Gagliano D; Immediata V; Lanzone A; Guido M Reprod Sci; 2016 May; 23(5):655-61. PubMed ID: 26718304 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms. Ciftci CF; Uckuyu A; Karadeli E; Turhan E; Toprak E; Ozcimen EE Ginekol Pol; 2012 Dec; 83(12):910-5. PubMed ID: 23488293 [TBL] [Abstract][Full Text] [Related]
14. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. Dewailly D; Catteau-Jonard S; Reyss AC; Leroy M; Pigny P J Clin Endocrinol Metab; 2006 Oct; 91(10):3922-7. PubMed ID: 16849400 [TBL] [Abstract][Full Text] [Related]
15. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073 [TBL] [Abstract][Full Text] [Related]
16. Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics. Ates S; Sevket O; Sudolmus S; Dane B; Ozkal F; Uysal O; Dansuk R Gynecol Endocrinol; 2013 Oct; 29(10):931-5. PubMed ID: 23998514 [TBL] [Abstract][Full Text] [Related]
17. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals. Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383 [TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes. Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943 [TBL] [Abstract][Full Text] [Related]
20. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes. Moro F; Tropea A; Scarinci E; Federico A; De Simone C; Caldarola G; Leoncini E; Boccia S; Lanzone A; Apa R Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():101-5. PubMed ID: 26115053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]